A detailed history of State Street Corp transactions in Scynexis Inc stock. As of the latest transaction made, State Street Corp holds 107,330 shares of SCYX stock, worth $108,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,330
Previous 107,330 -0.0%
Holding current value
$108,403
Previous $214,000 25.7%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.4 - $2.77 $1,680 - $3,324
1,200 Added 1.13%
107,330 $214,000
Q1 2023

May 15, 2023

BUY
$1.15 - $3.0 $31,624 - $82,500
27,500 Added 34.97%
106,130 $318,000
Q1 2022

May 16, 2022

BUY
$3.56 - $6.66 $23,830 - $44,582
6,694 Added 9.31%
78,630 $307,000
Q2 2021

Aug 16, 2021

BUY
$6.5 - $9.97 $467,584 - $717,201
71,936 New
71,936 $529,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.